z-logo
Premium
Characterization of the binding of a novel radioligand to CCK B /gastrin receptors in membranes from rat cerebral cortex
Author(s) -
Harper E A,
Shankley N P,
Black J W
Publication year - 1999
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702447
Subject(s) - radioligand , receptor , gastrin , chemistry , population , radioligand assay , cortex (anatomy) , medicine , membrane , endocrinology , biology , biochemistry , environmental health , neuroscience , secretion
We have investigated the binding of a novel radiolabelled CCK B /gastrin receptor ligand, [ 3 H]‐JB93182 (5[[[(1S)‐[[(3,5‐dicarboxyphenyl)amino]carbonyl]‐2‐phenylethylamino]‐carbonyl]‐6‐[[(1‐adamantylmethyl) amino]carbonyl]‐indole), to sites in rat cortex membranes. The [ 3 H]‐JB93182 was 97% radiochemically pure as assessed by reverse‐phase HPLC (RP‐HPLC) and was not degraded by incubation (150 min) with rat cortex membranes. Saturation analysis indicated that [ 3 H]‐JB93182 labelled a homogeneous population of receptors in rat cortex membranes (pK D =9.48±0.08, B max =3.61∼plusmn;0.65 pmol g −1 tissue, n H =0.97±0.02, n =5). The pK D was not significantly different when estimated by association‐dissociation analysis (pK D =9.73±0.11; n =10). In competition studies, the low affinity of the CCK A receptor antagonists, L‐364,718; SR27897 and 2‐NAP, suggest that, under the assay conditions employed, [ 3 H]‐JB93182 (0.3 n M ) does not label CCK A receptors in the rat cortex. The affinity estimates obtained for reference CCK B /gastrin receptor antagonists were indistinguishable from one of the affinity values obtained when a two site model was used to interpret [ 125 I]‐BH‐CCK8S competition curves obtained in the same tissue ( Harper et al ., 1999 ). This study provides further evidence for the existence of two CCK B /gastrin sites in rat cortex. [ 3 H]‐JB93182 appears to label selectively sites previously designated as gastrin‐G 1 and therefore it may be a useful compound for the further discrimination and characterization of these putative receptor subtypes.British Journal of Pharmacology (1999) 126 , 1504–1512; doi: 10.1038/sj.bjp.0702447

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom